Immunosuppressive therapies in myasthenia gravis

Development of novel therapies for MG: Studies in animal models

(2010) M. C. Souroujon et al.   AUTOIMMUNITY

Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis

(2010) George Lagoumintzis et al.   AUTOIMMUNITY

Myasthenia gravis associated with etanercept therapy

(2009) Dominic B. Fee et al.   MUSCLE & NERVE

Lessons from Two Trials of Mycophenolate Mofetil in Myasthenia Gravis

(2008) Donald B. Sanders et al.   Annals of the New York Academy of Sciences

Mycophenolate mofetil in myasthenia gravis: the unanswered question

(2008) C Phan et al.   EXPERT OPINION ON PHARMACOTHERAPY

B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders

(2008) J STUBGEN   JOURNAL OF NEUROIMMUNOLOGY

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients

(2008) Isabel Illa et al.   JOURNAL OF NEUROIMMUNOLOGY

MuSK-antibody positive myasthenia gravis: Questions from the clinic

(2008) Donald B. Sanders et al.   JOURNAL OF NEUROIMMUNOLOGY

Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis

(2008) Samar Kerkeni et al.   MUSCLE & NERVE

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

(2008)   NEUROLOGY

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

(2008) D. B. Sanders et al.   NEUROLOGY

Current and future standards in treatment of myasthenia gravis

(2008) Ralf Gold et al.   Neurotherapeutics